Covid-19 roundup: Ahead of FDA, EU signs off on Mer­ck­'s an­tivi­ral; Dis­tri­b­u­tion of mAbs in US see first uptick in 7 weeks

The Eu­ro­pean Med­i­cines Agency on Fri­day said that Mer­ck’s an­tivi­ral mol­nupi­ravir can now be used to treat adults with Covid-19 who do not re­quire sup­ple­men­tal …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER